Consequently VIP must exist in relatively high concentrations to initiate a physiological effect. VIP formulations prepared with this method could promote wound healing in various organs and for various time periods such as, but not limited to skin, hair follicles, gut and oral mucosa. This technology extends the time period for VIP action and reduces the level of VIP needed to cause a physiological effect.
Animal studies are in progress.
The concept is ready for clinical testing. If you want to expedite the receipt of this information, please fax a signed copy of the CDA to the contact. If you wish to modify the CDA, please discuss it with the contact.